Evidence map›Paper›PMID 25923723›Full record

ArticlePLoS pathogens2015

Optineurin regulates the interferon response in a cell cycle-dependent manner.

Pierre Génin, Frédérique Cuvelier, Sandrine Lambin, Josina Côrte-Real Filipe, Elodie Autrusseau, Christine Laurent, Emmanuel Laplantine, Robert Weil

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Optineurin Shapes Basal and LPS-Induced Transcriptomes in BV2 Microglia.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Deubiquitylating Enzymes in Cancer and Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  6. Article
  7. Optineurin in ocular herpes infection.Experimental eye research · 2022
    Review
  8. Article
  9. Mitochondrial function in development and disease.Disease models & mechanisms · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pierre GéninLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Frédérique CuvelierLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Sandrine LambinLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Josina Côrte-Real FilipeLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Elodie AutrusseauLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Christine LaurentPlate-Forme Protéomique, Institut Pasteur, Paris, France.
Emmanuel LaplantineLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Robert WeilLaboratoire de Signalisation et Pathogenèse, CNRS UMR3691, Institut Pasteur, Paris, France.
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral invasion into a host is initially recognized by the innate immune system, mainly through activation of the intracellular cytosolic signaling pathway and coordinated activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB) transcription factors that promote type I interferon gene induction. The TANK-binding Kinase 1 (TBK1) phosphorylates and activates IRF3. Here, we show that Optineurin (Optn) dampens the antiviral innate immune response by targeting the deubiquitinating enzyme CYLD to TBK1 in order to inhibit its enzymatic activity. Importantly, we found that this regulatory mechanism is abolished at the G2/M phase as a consequence of the nuclear translocation of CYLD and Optn. As a result, we observed, at this cell division stage, an increased activity and phosphorylation of TBK1 that lead to its relocalization to mitochondria and to enhanced interferon production, suggesting that this process, which relies on Optn function, might be of major importance to mount a preventive antiviral response during mitosis.

Indexed as

Immunity, InnateMitosisUp-RegulationActive Transport, Cell NucleusAmino Acid SubstitutionCell Cycle ProteinsCell LineDeubiquitinating Enzyme CYLDG2 PhaseGenes, ReporterHumansInterferon-betaMembrane Transport ProteinsMutationPhosphorylationProtein Processing, Post-TranslationalCell Cycle ProteinsCYLD protein, humanDeubiquitinating Enzyme CYLDInterferon-betaMembrane Transport ProteinsOPTN protein, humanProtein Serine-Threonine KinasesRecombinant ProteinsRNA, Small InterferingTBK1 protein, humanTranscription Factor TFIIIATumor Suppressor Proteins

Identifiers

PMID25923723
PMCPMC4414543
OpenAlexW2032996510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.